Thank you for choosing to receive our email communications. 

Here are a few of the latest society announcements:

Council Election Results

The results are in – please join us in congratulating the newly elected IGCS Council Members. For each position, the candidate receiving the most votes was elected. Regional Council Members were elected by IGCS Members residing in the corresponding region.

IGCS 2022 Annual Global Meeting

Registration and Housing is NOW OPEN! IGCS will offer in-person and virtual registration options for the 2022 IGCS Annual Global Meeting to be held September 29 – October 1. Registration features a flexible approach to allow ease of converting between an in-person and virtual ticket.

Introducing IGCS Advocacy Committee

We are pleased to announce that we have assembled an Advocacy Committee with the goal to advance gynecologic cancer awareness in alignment with our mission by guiding, supporting, and overseeing the International Gynecologic Cancer Advocacy Network as well as other advocacy initiatives, programs, and events.

Impact of the War in Ukraine on Cancer

Read more to learn of the recent developments from the Special Network on the Impact of the War in Ukraine on Cancer and the efforts of those working to address the issues and multifaceted challenges that have arisen for healthcare delivery in Ukraine and neighboring countries.

Interactive Updates on Selected Topics in Gynecology Oncology

Join us the first three Saturdays in May for the webinar titled Interactive Updates on Selected Topics in Gynecology Oncology. This webinar will be presented in Spanish, English and Portuguese. Register now!

Educational Webinars

The coming weeks are full of education from the IGCS Advances and Updates Workgroup. Mark your calendars and register for these informative virtual sessions.

Project GEOCC

The goal of Project GEOCC is to assess current practices, access to, and standards of care globally, and ultimately use this information to strive towards achieving equality and equity in care for all women affected by ovarian cancer. Please participate in our study.

See all updates here.